These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25971843)

  • 21. Cardiac myosin-binding protein C N-terminal interactions with myosin and actin filaments: Opposite effects of phosphorylation and M-domain mutations.
    Wong FL; Bunch TA; Lepak VC; Steedman AL; Colson BA
    J Mol Cell Cardiol; 2024 Jan; 186():125-137. PubMed ID: 38008210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice.
    Harris SP; Bartley CR; Hacker TA; McDonald KS; Douglas PS; Greaser ML; Powers PA; Moss RL
    Circ Res; 2002 Mar; 90(5):594-601. PubMed ID: 11909824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-directed spectroscopy of cardiac myosin-binding protein C reveals effects of phosphorylation on protein structural dynamics.
    Colson BA; Thompson AR; Espinoza-Fonseca LM; Thomas DD
    Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3233-8. PubMed ID: 26908877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization of the C3 domain of cardiac myosin binding protein C and its hypertrophic cardiomyopathy-related R502W mutant.
    Zhang XL; De S; McIntosh LP; Paetzel M
    Biochemistry; 2014 Aug; 53(32):5332-42. PubMed ID: 25058872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HCM-causing Y235S cMyBPC mutation accelerates contractile function by altering C1 domain structure.
    Doh CY; Li J; Mamidi R; Stelzer JE
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):661-677. PubMed ID: 30611859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships.
    Sequeira V; Witjas-Paalberends ER; Kuster DW; van der Velden J
    Pflugers Arch; 2014 Feb; 466(2):201-6. PubMed ID: 24240729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of the C1 domain of cardiac myosin binding protein-C: implications for hypertrophic cardiomyopathy.
    Govada L; Carpenter L; da Fonseca PC; Helliwell JR; Rizkallah P; Flashman E; Chayen NE; Redwood C; Squire JM
    J Mol Biol; 2008 Apr; 378(2):387-97. PubMed ID: 18374358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation.
    Harris SP; Belknap B; Van Sciver RE; White HD; Galkin VE
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1558-63. PubMed ID: 26831109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically Linked Mutations in the Central Domains of Cardiac Myosin-Binding Protein C with Distinct Phenotypes Show Differential Structural Effects.
    Nadvi NA; Michie KA; Kwan AH; Guss JM; Trewhella J
    Structure; 2016 Jan; 24(1):105-115. PubMed ID: 26688216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species-specific differences in the Pro-Ala rich region of cardiac myosin binding protein-C.
    Shaffer JF; Harris SP
    J Muscle Res Cell Motil; 2009 Dec; 30(7-8):303-6. PubMed ID: 20217194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains.
    Yang Q; Osinska H; Klevitsky R; Robbins J
    J Mol Cell Cardiol; 2001 Sep; 33(9):1649-58. PubMed ID: 11549344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of 8 sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy.
    Meurs KM; Norgard MM; Kuan M; Haggstrom J; Kittleson M
    J Vet Intern Med; 2009; 23(4):840-3. PubMed ID: 19566849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Cardiac Myosin Binding Protein C3 in Hypertrophic Cardiomyopathy-Progress and Novel Therapeutic Opportunities.
    Mohamed IA; Krishnamoorthy NT; Nasrallah GK; Da'as SI
    J Cell Physiol; 2017 Jul; 232(7):1650-1659. PubMed ID: 27731493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue.
    Dutsch A; Wijnker PJM; Schlossarek S; Friedrich FW; Krämer E; Braren I; Hirt MN; Brenière-Letuffe D; Rhoden A; Mannhardt I; Eschenhagen T; Carrier L; Mearini G
    Sci Rep; 2019 Dec; 9(1):18152. PubMed ID: 31796859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel protein kinase A phosphorylation sites in the M-domain of human and murine cardiac myosin binding protein-C using mass spectrometry analysis.
    Jia W; Shaffer JF; Harris SP; Leary JA
    J Proteome Res; 2010 Apr; 9(4):1843-53. PubMed ID: 20151718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
    Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
    J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.
    Singh RR; McNamara JW; Sadayappan S
    J Biol Chem; 2021 Jul; 297(1):100836. PubMed ID: 34051236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy.
    Suay-Corredera C; Pricolo MR; Velázquez-Carreras D; Pathak D; Nandwani N; Pimenta-Lopes C; Sánchez-Ortiz D; Urrutia-Irazabal I; Vilches S; Dominguez F; Frisso G; Monserrat L; García-Pavía P; de Sancho D; Spudich JA; Ruppel KM; Herrero-Galán E; Alegre-Cebollada J
    ACS Nano; 2021 Jun; 15(6):10203-10216. PubMed ID: 34060810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.